|
Market Closed -
Nasdaq
23:00:00 28/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 10.12 USD | +7.89% |
|
+6.47% | -44.52% |
| 08-06 | ADMA Biologics, Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-06 | Tranche Update on ADMA Biologics, Inc.'s Equity Buyback Plan announced on May 7, 2025. | CI |
| Market Cap | 2.27B 1.99B 1.89B 1.71B 3.21B 218B 3.23B 22.57B 8.72B 111B 8.51B 8.33B 357B | P/E 2026 * |
12.5x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.27B 1.99B 1.89B 1.71B 3.21B 218B 3.23B 22.57B 8.72B 111B 8.51B 8.33B 357B | EV / Sales 2026 * |
4.23x | EV / Sales 2027 * | 3.6x |
| Free-Float |
90.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADMA | Delayed | |
CBOE
| ADMA | Real-time |
Last Transcript: ADMA Biologics, Inc.
| 08/12/22 | Wall Street lager gesloten | |
| 07/12/22 | Wall Street koerst af op vlak slot | |
| 07/12/22 | Wall Street verder omlaag bij opening | |
| 07/12/22 | Futures Wall Street wijzen omlaag | |
| 30/03/17 | Chinesischer Investor hat Interesse an Biotest |
| 1 day | +7.89% | ||
| 1 week | +6.47% | ||
| Current month | +7.77% | ||
| 1 month | +8.35% | ||
| 3 months | +15.66% | ||
| 6 months | +9.41% | ||
| Current year | -44.52% |
| 1 week | 9.23 |  | 10.17 |
| 1 month | 8.54 | | 10.17 |
| Current year | 7.21 | | 18.95 |
| 1 year | 7.21 | | 20.46 |
| 3 years | 3.06 | | 25.67 |
| 5 years | 1.01 | | 25.67 |
| 10 years | 1.01 | | 25.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 49 | 01/10/2011 |
Paul Kohler
DFI | Director of Finance/CFO | 49 | 26/02/2026 |
| Compliance Officer | 39 | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Jerrold Grossman
BRD | Director/Board Member | 78 | 01/01/2007 |
Steven Elms
CHM | Chairman | 62 | 30/03/2012 |
Adam Grossman
BRD | Director/Board Member | 49 | 01/01/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/24/26 A | Tax | Compliance Officer | -3,177 | 0.0014% | ||
| 7/16/26 A | Free | Chief Financial Officer | 221,493 | 0.0956% | ||
| 5/27/26 A | Buy | Founder | 6,400 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.89% | +6.47% | -35.17% | +185.88% | 2.1B | |
| -0.80% | +14.07% | +705.55% | +96.75% | 79.4B | |
| -4.54% | -5.75% | +33.40% | -9.86% | 78.69B | |
| +0.15% | +0.75% | -8.50% | -27.40% | 59.52B | |
| -0.89% | +0.19% | +7.92% | +172.79% | 46.58B | |
| +2.49% | -0.14% | -8.95% | +33.71% | 46.53B | |
| +0.48% | +4.39% | +66.48% | -11.30% | 33.63B | |
| +0.75% | +0.14% | +50.93% | +112.97% | 25.11B | |
| +0.88% | -6.01% | +3.53% | +153.33% | 22.13B | |
| +0.73% | -0.95% | +61.19% | +97.04% | 15.31B | |
| Average | +0.79% | +2.12% | +87.64% | +80.39% | 40.9B | |
| Weighted average by Cap. | -0.46% | +2.26% | +152.94% | +55.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 535M 471M 445M 404M 758M 51.39B 763M 5.33B 2.06B 26.22B 2.01B 1.97B 84.27B | 630M 554M 524M 475M 892M 60.43B 897M 6.27B 2.42B 30.84B 2.36B 2.31B 99.09B |
| Net income | 191M 168M 159M 144M 271M 18.36B 273M 1.9B 736M 9.37B 718M 703M 30.11B | 223M 196M 185M 168M 315M 21.38B 317M 2.22B 856M 10.91B 836M 818M 35.05B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/09/26 | $10.12 | +7.89% | 3,568,281 |
| 25/09/26 | $9.380 | -1.47% | 3,566,680 |
| 24/09/26 | $9.520 | -1.86% | 2,586,547 |
| 23/09/26 | $9.700 | -1.12% | 2,595,478 |
| 22/09/26 | $9.810 | +3.21% | 2,737,632 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADMA Stock
Select your edition
All financial news and data tailored to specific country editions
